Elyse E. Lower

Jan 18, 2024 | chestmed.theclinics.com | Robert P. Baughman |Elyse E. Lower |Marc A. Judson

This site can’t provide a secure connection acw.secure.jbs.elsevierhealth.com uses an unsupported protocol.

Sep 7, 2023 | respiratory-research.biomedcentral.com | Ying Zhou |Mengmeng Zhao |Elyse E. Lower |Robert P. Baughman |Xianqiu Chen

ReferencesRossides M, Darlington P, Kullberg S, Arkema EV, Sarcoidosis. Epidemiology and clinical insights. J INTERN MED [Journal Article; Review]. 2023 2023-06-01;293(6):668–80. Ying Z, Elyse EL, Yinping F, Shanshan D, Huiping L, Robert PB. Clinical characteristics of sarcoidosis patients in the United States versus China. Sarcoidosis Vasc Diffuse Lung Dis [Journal Article]. 2017 2017-01-20;34(3):209–16. Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R et al.

May 24, 2023 | thelancet.com | Roberto G. Carbone |Elyse E. Lower |Robert P. Baughman |Francesco Puppo

Vivienne Kahlmann and colleagues1Kahlmann V Moor CC van Helmondt SJ et al. Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial. did a randomised controlled trial to assess the effect of a 12-week online mindfulness-based cognitive therapy (eMBCT) on fatigue in sarcoidosis. Kahlmann and colleagues1Kahlmann V Moor CC van Helmondt SJ et al.